JP2013519724A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013519724A5 JP2013519724A5 JP2012553434A JP2012553434A JP2013519724A5 JP 2013519724 A5 JP2013519724 A5 JP 2013519724A5 JP 2012553434 A JP2012553434 A JP 2012553434A JP 2012553434 A JP2012553434 A JP 2012553434A JP 2013519724 A5 JP2013519724 A5 JP 2013519724A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- pyrazolo
- hexahydro
- optionally substituted
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 substituted Chemical class 0.000 claims 13
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 12
- 125000001072 heteroaryl group Chemical group 0.000 claims 12
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 9
- 125000003107 substituted aryl group Chemical group 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- GKECDORWWXXNRY-UHFFFAOYSA-N 2h-pyridin-3-one Chemical compound O=C1CN=CC=C1 GKECDORWWXXNRY-UHFFFAOYSA-N 0.000 claims 5
- RTTBBADOMOOPTQ-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-b]pyridine Chemical class C1CCNC2=C1NN=C2 RTTBBADOMOOPTQ-UHFFFAOYSA-N 0.000 claims 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 3
- KMPMTELUDJZGLM-UHFFFAOYSA-N 2,5-dibenzyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(CC=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=CC=C1 KMPMTELUDJZGLM-UHFFFAOYSA-N 0.000 claims 2
- MSLXXVXVASCLGG-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-5-[(4-chlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1CN1CC(C(=O)N(C=2C=C3OCOC3=CC=2)N2)=C2CC1 MSLXXVXVASCLGG-UHFFFAOYSA-N 0.000 claims 2
- TZNRCUWFPYPPMY-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-5-[(4-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(C=2C=C3OCOC3=CC=2)N2)=C2CC1 TZNRCUWFPYPPMY-UHFFFAOYSA-N 0.000 claims 2
- RYZISLNAQUCHEB-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-5-[(4-methylsulfonylphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CN1CC(C(=O)N(C=2C=C3OCOC3=CC=2)N2)=C2CC1 RYZISLNAQUCHEB-UHFFFAOYSA-N 0.000 claims 2
- NLIIFVXJSJMVAM-UHFFFAOYSA-N 2-(2-fluorophenyl)-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound FC1=CC=CC=C1N1C(=O)C(CN(CC=2C=NC=CC=2)CC2)=C2N1 NLIIFVXJSJMVAM-UHFFFAOYSA-N 0.000 claims 2
- KFOSIZPIWHVOKY-UHFFFAOYSA-N 2-(2-hydroxyethyl)-5-[(4-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(CCO)N2)=C2CC1 KFOSIZPIWHVOKY-UHFFFAOYSA-N 0.000 claims 2
- NSZAEAYIHSNZLK-UHFFFAOYSA-N 2-(2-methoxyethyl)-5-[(4-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(CCOC)NC=2CCN1CC1=CC=C(OC)C=C1 NSZAEAYIHSNZLK-UHFFFAOYSA-N 0.000 claims 2
- FAZQTVRCISFNSB-UHFFFAOYSA-N 2-(2-methyl-1,3-benzothiazol-6-yl)-5-(pyridin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=CC=N1 FAZQTVRCISFNSB-UHFFFAOYSA-N 0.000 claims 2
- ZGUZDIDQNIPNSF-UHFFFAOYSA-N 2-(2-methyl-1,3-benzothiazol-6-yl)-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=CN=C1 ZGUZDIDQNIPNSF-UHFFFAOYSA-N 0.000 claims 2
- NNJNFAWSUKXJIO-UHFFFAOYSA-N 2-(2-methyl-1,3-benzothiazol-6-yl)-5-[(4-methylsulfonylphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=C(S(C)(=O)=O)C=C1 NNJNFAWSUKXJIO-UHFFFAOYSA-N 0.000 claims 2
- QHMKECIARRUGGA-UHFFFAOYSA-N 2-(2-methyl-1,3-benzothiazol-6-yl)-5-[[3-(trifluoromethyl)phenyl]methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=CC(C(F)(F)F)=C1 QHMKECIARRUGGA-UHFFFAOYSA-N 0.000 claims 2
- ZISOBPVMGZLFBU-UHFFFAOYSA-N 2-(3-methoxyphenyl)-5-(pyridin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4N=CC=CC=4)CCC=3N2)=O)=C1 ZISOBPVMGZLFBU-UHFFFAOYSA-N 0.000 claims 2
- DYLYFEADADAEKQ-UHFFFAOYSA-N 2-(3-methoxyphenyl)-5-[(4-phenylmethoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C=CC(OCC=5C=CC=CC=5)=CC=4)CCC=3N2)=O)=C1 DYLYFEADADAEKQ-UHFFFAOYSA-N 0.000 claims 2
- UEACRNOYALDGCN-UHFFFAOYSA-N 2-(4-chlorophenyl)-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(CN(CC=2C=NC=CC=2)CC2)=C2N1 UEACRNOYALDGCN-UHFFFAOYSA-N 0.000 claims 2
- WCZQRJQFJUFSBM-UHFFFAOYSA-N 2-(4-chlorophenyl)-5-[(6-chloropyridin-3-yl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(CN(CC=2C=NC(Cl)=CC=2)CC2)=C2N1 WCZQRJQFJUFSBM-UHFFFAOYSA-N 0.000 claims 2
- DMUJTXHJTLRTFT-UHFFFAOYSA-N 2-(imidazo[1,2-a]pyridin-2-ylmethyl)-5-(4-methylphenyl)sulfonyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(C(=O)N(CC=2N=C3C=CC=CN3C=2)N2)=C2CC1 DMUJTXHJTLRTFT-UHFFFAOYSA-N 0.000 claims 2
- HRNRSZZIOPOOHA-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methyl]-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC=C1CN1C(=O)C(CN(CC=2C=NC=CC=2)CC2)=C2N1 HRNRSZZIOPOOHA-UHFFFAOYSA-N 0.000 claims 2
- UMQOBSSEPIBXJA-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methyl]-5-[(4-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(CC=2C(=CC=CC=2)OC)N2)=C2CC1 UMQOBSSEPIBXJA-UHFFFAOYSA-N 0.000 claims 2
- AOEPYPXMYVFQGI-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(CN2C(C=3CN(CC=4C=NC=CC=4)CCC=3N2)=O)=C1 AOEPYPXMYVFQGI-UHFFFAOYSA-N 0.000 claims 2
- HYPRWZQSFIMVOE-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]-5-[(4-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(CC=2C=C(OC)C=CC=2)N2)=C2CC1 HYPRWZQSFIMVOE-UHFFFAOYSA-N 0.000 claims 2
- HZUUJMNCGZMIMV-UHFFFAOYSA-N 2-[2-(4-chlorophenoxy)ethyl]-5-[(4-methoxyphenyl)methyl]-1,3a,4,6,7,7a-hexahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC2C(=O)N(CCOC=3C=CC(Cl)=CC=3)NC2CC1 HZUUJMNCGZMIMV-UHFFFAOYSA-N 0.000 claims 2
- HYCGNGLYTNISJG-UHFFFAOYSA-N 2-benzyl-5-(pyridin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(CC=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=CC=N1 HYCGNGLYTNISJG-UHFFFAOYSA-N 0.000 claims 2
- BMRMPINGYPPQEA-UHFFFAOYSA-N 2-benzyl-5-[(2,4-dichlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound ClC1=CC(Cl)=CC=C1CN1CC(C(=O)N(CC=2C=CC=CC=2)N2)=C2CC1 BMRMPINGYPPQEA-UHFFFAOYSA-N 0.000 claims 2
- XDYTVJRRXCISHF-UHFFFAOYSA-N 2-benzyl-5-[(3,4-dichlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(C(=O)N(CC=2C=CC=CC=2)N2)=C2CC1 XDYTVJRRXCISHF-UHFFFAOYSA-N 0.000 claims 2
- UDUWUZWRUZZOBQ-UHFFFAOYSA-N 2-benzyl-5-[(3,5-dichlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound ClC1=CC(Cl)=CC(CN2CC=3C(=O)N(CC=4C=CC=CC=4)NC=3CC2)=C1 UDUWUZWRUZZOBQ-UHFFFAOYSA-N 0.000 claims 2
- DVHJCTHTLRUBPC-UHFFFAOYSA-N 2-benzyl-5-[(3,5-dimethoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC(OC)=CC(CN2CC=3C(=O)N(CC=4C=CC=CC=4)NC=3CC2)=C1 DVHJCTHTLRUBPC-UHFFFAOYSA-N 0.000 claims 2
- VDEYOADUTDTYKW-UHFFFAOYSA-N 2-benzyl-5-[(3-chloro-4-fluorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C(Cl)C(F)=CC=C1CN1CC(C(=O)N(CC=2C=CC=CC=2)N2)=C2CC1 VDEYOADUTDTYKW-UHFFFAOYSA-N 0.000 claims 2
- SYENWDPXFSLRND-UHFFFAOYSA-N 2-benzyl-5-[(3-chlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound ClC1=CC=CC(CN2CC=3C(=O)N(CC=4C=CC=CC=4)NC=3CC2)=C1 SYENWDPXFSLRND-UHFFFAOYSA-N 0.000 claims 2
- XGELNRUSJOBKMV-UHFFFAOYSA-N 2-benzyl-5-[(3-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(CN2CC=3C(=O)N(CC=4C=CC=CC=4)NC=3CC2)=C1 XGELNRUSJOBKMV-UHFFFAOYSA-N 0.000 claims 2
- MGEBTRCHBGFTBE-UHFFFAOYSA-N 2-benzyl-5-[(4-chlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1CN1CC(C(=O)N(CC=2C=CC=CC=2)N2)=C2CC1 MGEBTRCHBGFTBE-UHFFFAOYSA-N 0.000 claims 2
- WKNWGQVNORKXCO-UHFFFAOYSA-N 2-benzyl-5-[(4-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(CC=2C=CC=CC=2)N2)=C2CC1 WKNWGQVNORKXCO-UHFFFAOYSA-N 0.000 claims 2
- TXTPFFPIHIHGGZ-UHFFFAOYSA-N 2-benzyl-5-[(6-chloropyridin-3-yl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=NC(Cl)=CC=C1CN1CC(C(=O)N(CC=2C=CC=CC=2)N2)=C2CC1 TXTPFFPIHIHGGZ-UHFFFAOYSA-N 0.000 claims 2
- UYDCAQTZYYBNMQ-UHFFFAOYSA-N 2-benzyl-5-methylsulfonyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(S(=O)(=O)C)CCC=2NN1CC1=CC=CC=C1 UYDCAQTZYYBNMQ-UHFFFAOYSA-N 0.000 claims 2
- JXPHMWUWWPQRIJ-UHFFFAOYSA-N 2-phenyl-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(C=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=CN=C1 JXPHMWUWWPQRIJ-UHFFFAOYSA-N 0.000 claims 2
- JLWSIOHQGBPHMA-UHFFFAOYSA-N 3-[3-oxo-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound C1CC=2NN(C=3C=C(C=CC=3)C#N)C(=O)C=2CN1CC1=CC=CN=C1 JLWSIOHQGBPHMA-UHFFFAOYSA-N 0.000 claims 2
- NVJHAYQWBUUOHP-UHFFFAOYSA-N 3-[3-oxo-5-[[3-(trifluoromethyl)phenyl]methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(CN2CC=3C(=O)N(C=4C=C(C=CC=4)C#N)NC=3CC2)=C1 NVJHAYQWBUUOHP-UHFFFAOYSA-N 0.000 claims 2
- ANMMZJDZZMDJNA-UHFFFAOYSA-N 3-[5-[(3-chloro-4-fluorophenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound C1=C(Cl)C(F)=CC=C1CN1CC(C(=O)N(C=2C=C(C=CC=2)C#N)N2)=C2CC1 ANMMZJDZZMDJNA-UHFFFAOYSA-N 0.000 claims 2
- JMQKBJPRXWKQPV-UHFFFAOYSA-N 3-[5-[(4-chlorophenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1CN1CC(C(=O)N(C=2C=C(C=CC=2)C#N)N2)=C2CC1 JMQKBJPRXWKQPV-UHFFFAOYSA-N 0.000 claims 2
- ZVWRZVMOGXVZOW-UHFFFAOYSA-N 3-[5-[(6-chloropyridin-3-yl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound C1=NC(Cl)=CC=C1CN1CC(C(=O)N(C=2C=C(C=CC=2)C#N)N2)=C2CC1 ZVWRZVMOGXVZOW-UHFFFAOYSA-N 0.000 claims 2
- RGXGWBFPZNOGPW-UHFFFAOYSA-N 3-[[2-(2-methyl-1,3-benzothiazol-6-yl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=CC(C#N)=C1 RGXGWBFPZNOGPW-UHFFFAOYSA-N 0.000 claims 2
- 125000000984 3-chloro-4-fluorobenzyl group Chemical group [H]C1=C(F)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 2
- CSHZQYUUJUNVQV-UHFFFAOYSA-N 3-fluoro-4-[[2-(2-methyl-1,3-benzothiazol-6-yl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=C(C#N)C=C1F CSHZQYUUJUNVQV-UHFFFAOYSA-N 0.000 claims 2
- XABOZUZUESTPPY-UHFFFAOYSA-N 3a-benzyl-5-[(4-chlorophenyl)methyl]-2-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-3-one Chemical compound C1C2(CC=3C=CC=CC=3)C(=O)N(C)N=C2CCN1CC1=CC=C(Cl)C=C1 XABOZUZUESTPPY-UHFFFAOYSA-N 0.000 claims 2
- HSWCBWVBJFLVMT-UHFFFAOYSA-N 4-[(2-benzyl-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)methyl]benzonitrile Chemical compound C1CC=2NN(CC=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=C(C#N)C=C1 HSWCBWVBJFLVMT-UHFFFAOYSA-N 0.000 claims 2
- FNJFPVVOXMEHRH-UHFFFAOYSA-N 4-[5-[(4-chlorophenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1CN1CC(C(=O)N(C=2C=CC(=CC=2)C#N)N2)=C2CC1 FNJFPVVOXMEHRH-UHFFFAOYSA-N 0.000 claims 2
- HKMIKSVZRAGCMJ-UHFFFAOYSA-N 4-[5-[(6-chloropyridin-3-yl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]benzonitrile Chemical compound C1=NC(Cl)=CC=C1CN1CC(C(=O)N(C=2C=CC(=CC=2)C#N)N2)=C2CC1 HKMIKSVZRAGCMJ-UHFFFAOYSA-N 0.000 claims 2
- ZCOWWFDUPKYTFH-UHFFFAOYSA-N 4-[[2-(1,3-benzodioxol-5-yl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1CC=2NN(C=3C=C4OCOC4=CC=3)C(=O)C=2CN1CC1=CC=C(C#N)C=C1 ZCOWWFDUPKYTFH-UHFFFAOYSA-N 0.000 claims 2
- NZMCPKDOUPMLRX-UHFFFAOYSA-N 4-[[2-(2-fluorophenyl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound FC1=CC=CC=C1N1C(=O)C(CN(CC=2C=CC(=CC=2)C#N)CC2)=C2N1 NZMCPKDOUPMLRX-UHFFFAOYSA-N 0.000 claims 2
- BNQSWOGSBZOBLN-UHFFFAOYSA-N 4-[[2-(2-hydroxyethyl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1C=2C(=O)N(CCO)NC=2CCN1CC1=CC=C(C#N)C=C1 BNQSWOGSBZOBLN-UHFFFAOYSA-N 0.000 claims 2
- DHDRIPLNGBVTEP-UHFFFAOYSA-N 4-[[2-(2-methyl-1,3-benzothiazol-6-yl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=C(C#N)C=C1 DHDRIPLNGBVTEP-UHFFFAOYSA-N 0.000 claims 2
- KBIQWEDKTDFZEM-UHFFFAOYSA-N 4-[[2-(3-methoxyphenyl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C=CC(=CC=4)C#N)CCC=3N2)=O)=C1 KBIQWEDKTDFZEM-UHFFFAOYSA-N 0.000 claims 2
- FJIHSDZFHIEHSX-UHFFFAOYSA-N 4-[[2-(4-chlorophenyl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(CN(CC=2C=CC(=CC=2)C#N)CC2)=C2N1 FJIHSDZFHIEHSX-UHFFFAOYSA-N 0.000 claims 2
- WQZAKMZSGPBIPB-UHFFFAOYSA-N 4-[[2-(4-methoxyphenyl)-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(CN(CC=2C=CC(=CC=2)C#N)CC2)=C2N1 WQZAKMZSGPBIPB-UHFFFAOYSA-N 0.000 claims 2
- BQGAGLRRHJUASH-UHFFFAOYSA-N 4-[[2-[(2-methoxyphenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound COC1=CC=CC=C1CN1C(=O)C(CN(CC=2C=CC(=CC=2)C#N)CC2)=C2N1 BQGAGLRRHJUASH-UHFFFAOYSA-N 0.000 claims 2
- QKXSHACDEDMFNR-UHFFFAOYSA-N 4-[[2-[(3-methoxyphenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound COC1=CC=CC(CN2C(C=3CN(CC=4C=CC(=CC=4)C#N)CCC=3N2)=O)=C1 QKXSHACDEDMFNR-UHFFFAOYSA-N 0.000 claims 2
- BMWOMNBUOAVJQI-UHFFFAOYSA-N 4-[[2-[(4-methoxyphenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1=CC(OC)=CC=C1CN1C(=O)C(CN(CC=2C=CC(=CC=2)C#N)CC2)=C2N1 BMWOMNBUOAVJQI-UHFFFAOYSA-N 0.000 claims 2
- HCYCSPMSWMDIJU-UHFFFAOYSA-N 4-[[3-oxo-2-(2-piperidin-1-ylethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]methyl]benzonitrile Chemical compound C1CC=2NN(CCN3CCCCC3)C(=O)C=2CN1CC1=CC=C(C#N)C=C1 HCYCSPMSWMDIJU-UHFFFAOYSA-N 0.000 claims 2
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 2
- LKIXTJRUUVYWJM-UHFFFAOYSA-N 5-(2-phenoxyethyl)-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(C=3C=CC=CC=3)C(=O)C=2CN1CCOC1=CC=CC=C1 LKIXTJRUUVYWJM-UHFFFAOYSA-N 0.000 claims 2
- CQTTYEHPKJSPLG-UHFFFAOYSA-N 5-(4-methylphenyl)sulfonyl-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(C(=O)N(C=2C=CC=CC=2)N2)=C2CC1 CQTTYEHPKJSPLG-UHFFFAOYSA-N 0.000 claims 2
- LTVZALXAPQDEHS-UHFFFAOYSA-N 5-[(2,4-dichlorophenyl)methyl]-2-(3-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C(=CC(Cl)=CC=4)Cl)CCC=3N2)=O)=C1 LTVZALXAPQDEHS-UHFFFAOYSA-N 0.000 claims 2
- NICZTBWNLVKZSO-UHFFFAOYSA-N 5-[(2-chlorophenyl)methyl]-2-(3-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C(=CC=CC=4)Cl)CCC=3N2)=O)=C1 NICZTBWNLVKZSO-UHFFFAOYSA-N 0.000 claims 2
- ZLFBGKHABGPHJG-UHFFFAOYSA-N 5-[(3-chloro-4-fluorophenyl)methyl]-2-(2-methyl-1,3-benzothiazol-6-yl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=C(F)C(Cl)=C1 ZLFBGKHABGPHJG-UHFFFAOYSA-N 0.000 claims 2
- PTIWONVVKXTEBX-UHFFFAOYSA-N 5-[(3-chloro-4-fluorophenyl)methyl]-2-(4-chlorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C(Cl)C(F)=CC=C1CN1CC(C(=O)N(C=2C=CC(Cl)=CC=2)N2)=C2CC1 PTIWONVVKXTEBX-UHFFFAOYSA-N 0.000 claims 2
- KOIRZCHDSGZXNA-UHFFFAOYSA-N 5-[(3-chlorophenyl)methyl]-2-(3-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C=C(Cl)C=CC=4)CCC=3N2)=O)=C1 KOIRZCHDSGZXNA-UHFFFAOYSA-N 0.000 claims 2
- OBOIQEPEXXCBLD-UHFFFAOYSA-N 5-[(3-chlorophenyl)methyl]-2-methyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(C)NC=2CCN1CC1=CC=CC(Cl)=C1 OBOIQEPEXXCBLD-UHFFFAOYSA-N 0.000 claims 2
- HEAUNENNFPCHJV-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(1-methylpiperidin-4-yl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CN(C)CCC1N1C(=O)C(CN(CC=2C=CC(Cl)=CC=2)CC2)=C2N1 HEAUNENNFPCHJV-UHFFFAOYSA-N 0.000 claims 2
- NNPSYURULNVWIA-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(2-hydroxyethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(CCO)NC=2CCN1CC1=CC=C(Cl)C=C1 NNPSYURULNVWIA-UHFFFAOYSA-N 0.000 claims 2
- KBSUQMSGGKUBFX-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(2-methoxyethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(CCOC)NC=2CCN1CC1=CC=C(Cl)C=C1 KBSUQMSGGKUBFX-UHFFFAOYSA-N 0.000 claims 2
- JWSWYKVDHIQLAP-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(2-methyl-1,3-benzothiazol-6-yl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=C(Cl)C=C1 JWSWYKVDHIQLAP-UHFFFAOYSA-N 0.000 claims 2
- VVDRVIGOBFJPMU-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(2-morpholin-4-ylethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1CN1CC(C(=O)N(CCN2CCOCC2)N2)=C2CC1 VVDRVIGOBFJPMU-UHFFFAOYSA-N 0.000 claims 2
- RADAISFGUZBEMD-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(3-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C=CC(Cl)=CC=4)CCC=3N2)=O)=C1 RADAISFGUZBEMD-UHFFFAOYSA-N 0.000 claims 2
- JKKLSWJKXOGWQW-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-(4-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(CN(CC=2C=CC(Cl)=CC=2)CC2)=C2N1 JKKLSWJKXOGWQW-UHFFFAOYSA-N 0.000 claims 2
- FBQNLYWYSIYSBL-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[(2-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC=C1CN1C(=O)C(CN(CC=2C=CC(Cl)=CC=2)CC2)=C2N1 FBQNLYWYSIYSBL-UHFFFAOYSA-N 0.000 claims 2
- AMDHKJNCXJUHHU-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[(3-methoxyphenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(CN2C(C=3CN(CC=4C=CC(Cl)=CC=4)CCC=3N2)=O)=C1 AMDHKJNCXJUHHU-UHFFFAOYSA-N 0.000 claims 2
- UQDACGXPVIJDRO-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-methyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(C)NC=2CCN1CC1=CC=C(Cl)C=C1 UQDACGXPVIJDRO-UHFFFAOYSA-N 0.000 claims 2
- NNRSBEPFOPNZAO-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-methyl-3a-(pyridin-3-ylmethyl)-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-3-one Chemical compound C1C2(CC=3C=NC=CC=3)C(=O)N(C)N=C2CCN1CC1=CC=C(Cl)C=C1 NNRSBEPFOPNZAO-UHFFFAOYSA-N 0.000 claims 2
- NAROMPHLBKOKAK-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1CN1CC(C(=O)N(C=2C=CC=CC=2)N2)=C2CC1 NAROMPHLBKOKAK-UHFFFAOYSA-N 0.000 claims 2
- FMLKDGIEWJOHQR-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-2-methyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(C)N2)=C2CC1 FMLKDGIEWJOHQR-UHFFFAOYSA-N 0.000 claims 2
- IVJZHIVEOKTTHA-UHFFFAOYSA-N 5-[(6-chloropyridin-3-yl)methyl]-2-(1-methylpiperidin-4-yl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CN(C)CCC1N1C(=O)C(CN(CC=2C=NC(Cl)=CC=2)CC2)=C2N1 IVJZHIVEOKTTHA-UHFFFAOYSA-N 0.000 claims 2
- YTALBISNLUTKEC-UHFFFAOYSA-N 5-[(6-chloropyridin-3-yl)methyl]-2-(2-fluorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound FC1=CC=CC=C1N1C(=O)C(CN(CC=2C=NC(Cl)=CC=2)CC2)=C2N1 YTALBISNLUTKEC-UHFFFAOYSA-N 0.000 claims 2
- IDHVSTFDWPIEAD-UHFFFAOYSA-N 5-[(6-chloropyridin-3-yl)methyl]-2-(2-methoxyethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(CCOC)NC=2CCN1CC1=CC=C(Cl)N=C1 IDHVSTFDWPIEAD-UHFFFAOYSA-N 0.000 claims 2
- IILBFTYPDQHQCU-UHFFFAOYSA-N 5-benzyl-2-(2-chloro-4-fluorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound ClC1=CC(F)=CC=C1N1C(=O)C(CN(CC=2C=CC=CC=2)CC2)=C2N1 IILBFTYPDQHQCU-UHFFFAOYSA-N 0.000 claims 2
- LGXAAGRYHFGQKL-UHFFFAOYSA-N 5-benzyl-2-(2-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC=C1N1C(=O)C(CN(CC=2C=CC=CC=2)CC2)=C2N1 LGXAAGRYHFGQKL-UHFFFAOYSA-N 0.000 claims 2
- HAMGHRIGEAPRPL-UHFFFAOYSA-N 5-benzyl-2-(3-chlorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound ClC1=CC=CC(N2C(C=3CN(CC=4C=CC=CC=4)CCC=3N2)=O)=C1 HAMGHRIGEAPRPL-UHFFFAOYSA-N 0.000 claims 2
- LPBRLXZOOFQRIU-UHFFFAOYSA-N 5-benzyl-2-(3-methoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound COC1=CC=CC(N2C(C=3CN(CC=4C=CC=CC=4)CCC=3N2)=O)=C1 LPBRLXZOOFQRIU-UHFFFAOYSA-N 0.000 claims 2
- NQMWROZHRTYZSD-UHFFFAOYSA-N 5-benzyl-2-(3-phenylmethoxyphenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(C=3C=C(OCC=4C=CC=CC=4)C=CC=3)C(=O)C=2CN1CC1=CC=CC=C1 NQMWROZHRTYZSD-UHFFFAOYSA-N 0.000 claims 2
- NPOAPKLRCNEVKL-UHFFFAOYSA-N 5-benzyl-2-[(4-chlorophenyl)methyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1CN1C(=O)C(CN(CC=2C=CC=CC=2)CC2)=C2N1 NPOAPKLRCNEVKL-UHFFFAOYSA-N 0.000 claims 2
- RUSLEORXLZGVHZ-UHFFFAOYSA-N 5-benzyl-2-[2-(4-chlorophenoxy)ethyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(Cl)=CC=C1OCCN1C(=O)C(CN(CC=2C=CC=CC=2)CC2)=C2N1 RUSLEORXLZGVHZ-UHFFFAOYSA-N 0.000 claims 2
- APOLWDJJWGJUCD-UHFFFAOYSA-N 5-benzyl-2-methyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)N(C)NC=2CCN1CC1=CC=CC=C1 APOLWDJJWGJUCD-UHFFFAOYSA-N 0.000 claims 2
- FPIPOTOBYXNMOK-UHFFFAOYSA-N 5-benzyl-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(C=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=CC=C1 FPIPOTOBYXNMOK-UHFFFAOYSA-N 0.000 claims 2
- LEMRYHURXLEJJZ-UHFFFAOYSA-N 5-methylsulfonyl-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(S(=O)(=O)C)CCC=2NN1C1=CC=CC=C1 LEMRYHURXLEJJZ-UHFFFAOYSA-N 0.000 claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 230000033115 angiogenesis Effects 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- BNTZTHNDTQGMBU-UHFFFAOYSA-N n-[3-[3-oxo-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(N2C(C=3CN(CC=4C=NC=CC=4)CCC=3N2)=O)=C1 BNTZTHNDTQGMBU-UHFFFAOYSA-N 0.000 claims 2
- NPEMLIKNDWRUQC-UHFFFAOYSA-N n-[3-[5-[(3-chloro-4-fluorophenyl)methyl]-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-2-yl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(N2C(C=3CN(CC=4C=C(Cl)C(F)=CC=4)CCC=3N2)=O)=C1 NPEMLIKNDWRUQC-UHFFFAOYSA-N 0.000 claims 2
- MTWMVHPHRCVMMV-UHFFFAOYSA-N n-[4-[(3-oxo-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CN1CC(C(=O)N(C=2C=CC=CC=2)N2)=C2CC1 MTWMVHPHRCVMMV-UHFFFAOYSA-N 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims 1
- CJLBRUMVRUVXJC-UHFFFAOYSA-N 2-(2-chloro-4-fluorophenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3-one Chemical compound ClC1=CC(F)=CC=C1N1C(=O)C(CNCC2)=C2N1 CJLBRUMVRUVXJC-UHFFFAOYSA-N 0.000 claims 1
- PRRHYVHHAPBLLV-UHFFFAOYSA-N 2-benzyl-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CNCCC=2NN1CC1=CC=CC=C1 PRRHYVHHAPBLLV-UHFFFAOYSA-N 0.000 claims 1
- PZMBBXPKGHCAJG-UHFFFAOYSA-N 2-benzyl-5-(pyridin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1CC=2NN(CC=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=CN=C1 PZMBBXPKGHCAJG-UHFFFAOYSA-N 0.000 claims 1
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- WPDSDEXJLCZUDR-UHFFFAOYSA-N 2-phenyl-5-propyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(CCC)CCC=2NN1C1=CC=CC=C1 WPDSDEXJLCZUDR-UHFFFAOYSA-N 0.000 claims 1
- GXQGTFOSFHZWCX-UHFFFAOYSA-N 3-[(2-benzyl-3-oxo-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)methyl]benzonitrile Chemical compound C1CC=2NN(CC=3C=CC=CC=3)C(=O)C=2CN1CC1=CC=CC(C#N)=C1 GXQGTFOSFHZWCX-UHFFFAOYSA-N 0.000 claims 1
- UEFJJIWOSRKCBI-UHFFFAOYSA-N 5-(3-methylbutyl)-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(CCC(C)C)CCC=2NN1C1=CC=CC=C1 UEFJJIWOSRKCBI-UHFFFAOYSA-N 0.000 claims 1
- RRXKFXKFDVWJBD-UHFFFAOYSA-N 5-[(2-chlorophenyl)methyl]-2-(2-methyl-1,3-benzothiazol-6-yl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=C2SC(C)=NC2=CC=C1N(C(C=1C2)=O)NC=1CCN2CC1=CC=CC=C1Cl RRXKFXKFDVWJBD-UHFFFAOYSA-N 0.000 claims 1
- BVZBJRSSDNRJKI-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-2-(1-methylpiperidin-4-yl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(C2CCN(C)CC2)N2)=C2CC1 BVZBJRSSDNRJKI-UHFFFAOYSA-N 0.000 claims 1
- ZIJSZDWCOCDEKK-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-2-(2-morpholin-4-ylethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound C1=CC(OC)=CC=C1CN1CC(C(=O)N(CCN2CCOCC2)N2)=C2CC1 ZIJSZDWCOCDEKK-UHFFFAOYSA-N 0.000 claims 1
- JLSFFUFNROMPPO-UHFFFAOYSA-N 5-benzyl-2,4,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3-one Chemical compound C1C=2C(=O)NNC=2CCN1CC1=CC=CC=C1 JLSFFUFNROMPPO-UHFFFAOYSA-N 0.000 claims 1
- ZGCAQZOMVOVRSM-UHFFFAOYSA-N 5-butyl-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(CCCC)CCC=2NN1C1=CC=CC=C1 ZGCAQZOMVOVRSM-UHFFFAOYSA-N 0.000 claims 1
- MLXGANPROYXHAU-UHFFFAOYSA-N 5-ethyl-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(CC)CCC=2NN1C1=CC=CC=C1 MLXGANPROYXHAU-UHFFFAOYSA-N 0.000 claims 1
- QKOKQHCOJNMPBE-UHFFFAOYSA-N 5-methyl-2-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-one Chemical compound O=C1C=2CN(C)CCC=2NN1C1=CC=CC=C1 QKOKQHCOJNMPBE-UHFFFAOYSA-N 0.000 claims 1
- 206010002199 Anaphylactic shock Diseases 0.000 claims 1
- 208000020084 Bone disease Diseases 0.000 claims 1
- AJPOAFHAPPAEEJ-UHFFFAOYSA-N CC1=NC2=C(S1)C=C(C=C2)N3C4=C(CNCC4)C(=O)N3 Chemical compound CC1=NC2=C(S1)C=C(C=C2)N3C4=C(CNCC4)C(=O)N3 AJPOAFHAPPAEEJ-UHFFFAOYSA-N 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 102100021217 Dual oxidase 2 Human genes 0.000 claims 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 claims 1
- 101000968308 Homo sapiens Dual oxidase 1 Proteins 0.000 claims 1
- 101000968305 Homo sapiens Dual oxidase 2 Proteins 0.000 claims 1
- 108010002998 NADPH Oxidases Proteins 0.000 claims 1
- 102000004722 NADPH Oxidases Human genes 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 206010049771 Shock haemorrhagic Diseases 0.000 claims 1
- 125000005024 alkenyl aryl group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000003027 ear inner Anatomy 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000003959 neuroinflammation Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003053 piperidines Chemical class 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10153927.8 | 2010-02-18 | ||
| EP10153927A EP2361911A1 (en) | 2010-02-18 | 2010-02-18 | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
| PCT/IB2011/050667 WO2011101804A1 (en) | 2010-02-18 | 2011-02-17 | Pyrazolo piperidine derivatives as nadph oxidase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013519724A JP2013519724A (ja) | 2013-05-30 |
| JP2013519724A5 true JP2013519724A5 (https=) | 2014-04-03 |
Family
ID=42617431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012553434A Pending JP2013519724A (ja) | 2010-02-18 | 2011-02-17 | Ｎａｄｐｈオキシダーゼ阻害剤としてのピラゾロピペリジン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8865758B2 (https=) |
| EP (2) | EP2361911A1 (https=) |
| JP (1) | JP2013519724A (https=) |
| KR (1) | KR20130010109A (https=) |
| CN (1) | CN102762563A (https=) |
| AU (1) | AU2011216893A1 (https=) |
| BR (1) | BR112012020736A2 (https=) |
| CA (1) | CA2789406A1 (https=) |
| ES (1) | ES2446727T3 (https=) |
| IL (1) | IL221207A (https=) |
| RU (1) | RU2012139828A (https=) |
| WO (1) | WO2011101804A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2002835A1 (en) | 2007-06-04 | 2008-12-17 | GenKyo Tex | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2165707A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2166010A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2166008A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2166009A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| EP2305679A1 (en) | 2009-09-28 | 2011-04-06 | GenKyoTex SA | Pyrazoline dione derivatives as nadph oxidase inhibitors |
| EP2361912A1 (en) | 2010-02-18 | 2011-08-31 | GenKyoTex SA | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
| EP2911667B1 (en) | 2012-10-24 | 2017-02-22 | Glucox Biotech AB | Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase |
| PL2931738T3 (pl) * | 2012-12-13 | 2019-07-31 | Aduro Biotech, Inc. | Kompozycje zawierające cykliczne dinukleotydy purynowe o zdefiniowanej stereochemii i sposoby ich otrzymywania i zastosowania |
| CN105315275B (zh) * | 2014-07-14 | 2019-10-01 | 中国科学院上海药物研究所 | 一类吡唑酮化合物及其用途 |
| US10173988B2 (en) | 2015-02-16 | 2019-01-08 | Glucox Biotech Ab | N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine |
| US10584118B2 (en) * | 2015-06-22 | 2020-03-10 | Actelion Pharmaceuticals Ltd | NADPH oxidase 4 inhibitors |
| EP3479843A1 (en) | 2017-11-01 | 2019-05-08 | GenKyoTex Suisse SA | Use of nox inhibitors for treatment of cancer |
| EA202193251A1 (ru) | 2019-06-05 | 2022-03-10 | Эмори Юниверсити | Пептидомиметики для лечения коронавирусной и пикорнавирусной инфекций |
| JP2023511302A (ja) * | 2020-01-13 | 2023-03-17 | アプタバイオ セラピューティクス インコーポレイテッド | 新規なピラゾール誘導体 |
| PH12022553516A1 (en) * | 2021-02-25 | 2024-06-03 | Aptabio Therapeutics Inc | Novel pyrazole derivatives |
| WO2025011546A1 (en) * | 2023-07-10 | 2025-01-16 | Acelon Therapeutics | Human caseinolytic protease p agonists and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| EP1219609B1 (en) * | 1999-09-16 | 2007-04-04 | Tanabe Seiyaku Co., Ltd. | Aromatic nitrogenous six-membered ring compounds |
| JP2004217654A (ja) * | 2002-12-27 | 2004-08-05 | Japan Tobacco Inc | 縮合ｎ含有へテロ環化合物及びその医薬用途 |
| US7947686B2 (en) * | 2005-12-12 | 2011-05-24 | Nerviano Medical Sciences S.R.L. | Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| EP2002835A1 (en) | 2007-06-04 | 2008-12-17 | GenKyo Tex | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2000176A1 (en) | 2007-06-04 | 2008-12-10 | GenKyo Tex | Tetrahydroindole derivatives as NADPH Oxidase inhibitors |
| EP2166008A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2166010A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| EP2166009A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| EP2165707A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| WO2010076525A1 (fr) * | 2008-12-29 | 2010-07-08 | Sanofi-Aventis | Dérivés de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur préparation et leur application en thérapeutique |
| EP2305679A1 (en) | 2009-09-28 | 2011-04-06 | GenKyoTex SA | Pyrazoline dione derivatives as nadph oxidase inhibitors |
| EP2361912A1 (en) | 2010-02-18 | 2011-08-31 | GenKyoTex SA | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
-
2010
- 2010-02-18 EP EP10153927A patent/EP2361911A1/en not_active Withdrawn
-
2011
- 2011-02-17 AU AU2011216893A patent/AU2011216893A1/en not_active Abandoned
- 2011-02-17 CN CN2011800096795A patent/CN102762563A/zh active Pending
- 2011-02-17 WO PCT/IB2011/050667 patent/WO2011101804A1/en not_active Ceased
- 2011-02-17 KR KR1020127021407A patent/KR20130010109A/ko not_active Withdrawn
- 2011-02-17 BR BR112012020736A patent/BR112012020736A2/pt not_active IP Right Cessation
- 2011-02-17 ES ES11709807.9T patent/ES2446727T3/es active Active
- 2011-02-17 CA CA2789406A patent/CA2789406A1/en not_active Abandoned
- 2011-02-17 JP JP2012553434A patent/JP2013519724A/ja active Pending
- 2011-02-17 EP EP11709807.9A patent/EP2536723B1/en active Active
- 2011-02-17 RU RU2012139828/04A patent/RU2012139828A/ru not_active Application Discontinuation
- 2011-02-17 US US13/579,290 patent/US8865758B2/en not_active Expired - Fee Related
-
2012
- 2012-07-31 IL IL221207A patent/IL221207A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013519724A5 (https=) | ||
| RU2012139828A (ru) | Производные пиразолопиперидина в качестве ингибиторов nadph-оксидазы | |
| JP2013520407A5 (https=) | ||
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| RU2485114C2 (ru) | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов | |
| JP2014524461A5 (https=) | ||
| RU2012139830A (ru) | Производные пиразолопиперидина в качестве ингибиторов nadph - оксидазы | |
| JP2009529047A5 (https=) | ||
| JP2012501327A5 (https=) | ||
| JP2012525431A5 (https=) | ||
| JP2020527560A5 (https=) | ||
| JP2008513514A5 (https=) | ||
| JP2007529484A5 (https=) | ||
| JP2020516671A5 (https=) | ||
| JP2016523911A5 (https=) | ||
| RU2015121948A (ru) | Агонист рецептора gpr40, способы его получения и фармацевтические композиции, содержащие его в качестве активного ингредиента | |
| JP2015517566A5 (https=) | ||
| JP2008523041A5 (https=) | ||
| JP2017535536A5 (https=) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| JP5552121B2 (ja) | ロイコトリエン産生のインドリジン阻害剤 | |
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| JP2004529926A5 (https=) | ||
| JP2014500322A5 (https=) |